IL146342A0 - Purine derivatives - Google Patents

Purine derivatives

Info

Publication number: IL146342A0
Authority: IL; Israel
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-10-14

Application number

IL14634200A

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2000-10-06

Publication date

2002-07-25

2000-10-06 Application filed by Pfizer filed Critical Pfizer

2002-07-25 Publication of IL146342A0 publication Critical patent/IL146342A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Hematology (AREA)
Oncology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)

IL14634200A 1999-10-14 2000-10-06 Purine derivatives IL146342A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9924363.6A GB9924363D0 (en)	1999-10-14	1999-10-14	Purine derivatives
PCT/IB2000/001444 WO2001027130A1 (fr)	1999-10-14	2000-10-06	Derives de purine

Publications (1)

Publication Number	Publication Date
IL146342A0 true IL146342A0 (en)	2002-07-25

Family

ID=10862760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14634200A IL146342A0 (en)	1999-10-14	2000-10-06	Purine derivatives

Country Status (50)

Country	Link
US (1)	US6350735B1 (fr)
EP (1)	EP1220863B1 (fr)
JP (1)	JP3994007B2 (fr)
KR (1)	KR20020037774A (fr)
CN (1)	CN1151167C (fr)
AP (1)	AP1442A (fr)
AR (1)	AR023275A1 (fr)
AT (1)	ATE238336T1 (fr)
AU (1)	AU768308B2 (fr)
BG (1)	BG106569A (fr)
BR (1)	BR0011776A (fr)
CA (1)	CA2387531C (fr)
CO (1)	CO5251399A1 (fr)
CR (1)	CR6584A (fr)
CZ (1)	CZ20021223A3 (fr)
DE (1)	DE60002356T2 (fr)
DK (1)	DK1220863T3 (fr)
DZ (1)	DZ3159A1 (fr)
EA (1)	EA004655B1 (fr)
EC (1)	ECSP003712A (fr)
EE (1)	EE200200193A (fr)
ES (1)	ES2193990T3 (fr)
GB (1)	GB9924363D0 (fr)
GE (1)	GEP20043269B (fr)
GT (1)	GT200000172A (fr)
HK (1)	HK1047110B (fr)
HN (1)	HN2000000204A (fr)
HU (1)	HUP0203483A2 (fr)
IL (1)	IL146342A0 (fr)
IS (1)	IS6165A (fr)
MA (1)	MA26828A1 (fr)
MX (1)	MXPA02003812A (fr)
MY (1)	MY136242A (fr)
NO (1)	NO20021692D0 (fr)
NZ (1)	NZ515323A (fr)
OA (1)	OA12059A (fr)
PA (1)	PA8503501A1 (fr)
PE (1)	PE20010755A1 (fr)
PL (1)	PL354932A1 (fr)
PT (1)	PT1220863E (fr)
SI (1)	SI1220863T1 (fr)
SK (1)	SK4842002A3 (fr)
SV (1)	SV2002000198A (fr)
TN (1)	TNSN00202A1 (fr)
TR (1)	TR200200985T2 (fr)
UA (1)	UA66945C2 (fr)
UY (1)	UY26397A1 (fr)
WO (1)	WO2001027130A1 (fr)
YU (1)	YU88901A (fr)
ZA (1)	ZA200202849B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
CZ20033126A3 (cs) *	2001-05-25	2004-09-15	Pfizer Inc.	Kombinace agonistu adenosin A2a receptoru a anticholinergického činidla pro ošetřování obstruktivních nemocí dýchacích cest
EP1434782A2 (fr) *	2001-10-01	2004-07-07	University of Virginia Patent Foundation	Analogues de 2-propynyle adenosine presentant une activite agoniste de a2a et compositions en contenant
AU2003234716A1 (en) *	2002-04-10	2003-10-27	Joel M. Linden	Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
US20050033044A1 (en) *	2003-05-19	2005-02-10	Bristol-Myers Squibb Pharma Company	Methods for preparing 2-alkynyladenosine derivatives
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
AU2005267706B2 (en) *	2004-08-02	2011-12-08	University Of Virginia Patent Foundation	2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
US7576069B2 (en) *	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7442687B2 (en) *	2004-08-02	2008-10-28	The University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
EP1893593A1 (fr) *	2005-06-15	2008-03-05	Pfizer Limited	Dérivés 3-phénylazétidine comme agonistes de la dopamine
CN100352823C (zh) *	2005-08-19	2007-12-05	浙江车头制药有限公司	一种腺嘌呤衍生物的制备方法
RU2421464C2 (ru)	2005-10-21	2011-06-20	Новартис Аг	Человеческие антитела к il-13 и их терапевтическое применение
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
WO2007092936A2 (fr) *	2006-02-08	2007-08-16	University Of Virginia Patent Foundation	Procédé pour traiter des lésions gastriques
WO2007120972A2 (fr)	2006-02-10	2007-10-25	University Of Virginia Patent Foundation	Procede permettant de traiter l'anemie a hematies falciformes
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
WO2008037477A1 (fr)	2006-09-29	2008-04-03	Novartis Ag	PYRAZOLOPYRIMIDINES UTILISÉES COMME INHIBITEURS DES LIPIDES KINASES Pl3K
CN101522682A (zh)	2006-10-30	2009-09-02	诺瓦提斯公司	作为抗炎剂的杂环化合物
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
MX2010007604A (es)	2008-01-11	2010-08-02	Novartis Ag	Pirimidinas como inhibidores de cinasa.
PT2391366E (pt)	2009-01-29	2013-02-05	Novartis Ag	Benzimidazoles substituídos para o tratamento de astrocitomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
JP5781510B2 (ja)	2009-08-12	2015-09-24	ノバルティスアーゲー	ヘテロ環式ヒドラゾン化合物および癌および炎症の処置のためのそれらの使用
PE20121148A1 (es)	2009-08-17	2012-09-07	Intellikine Llc	Compuestos heterociclicos y usos de los mismos
JP5775871B2 (ja)	2009-08-20	2015-09-09	ノバルティスアーゲー	ヘテロ環式オキシム化合物
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
WO2012034095A1 (fr)	2010-09-09	2012-03-15	Irm Llc	Composés et compositions comme inhibiteurs de trk
WO2012107500A1 (fr)	2011-02-10	2012-08-16	Novartis Ag	Composés de [1, 2, 4] triazolo [4, 3 -b] pyridazine en tant qu'inhibiteurs de la tyrosine kinase c-met
WO2012116237A2 (fr)	2011-02-23	2012-08-30	Intellikine, Llc	Composés hétérocycliques et leurs utilisations
WO2012116217A1 (fr)	2011-02-25	2012-08-30	Irm Llc	Composés et compositions en tant qu'inhibiteurs de trk
EA026655B1 (ru)	2011-09-15	2017-05-31	Новартис Аг	6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ
CA2856803A1 (fr)	2011-11-23	2013-05-30	Intellikine, Llc	Regimes de traitement ameliores utilisant des inhibiteurs de mtor
JP2015512425A (ja)	2012-04-03	2015-04-27	ノバルティスアーゲー	チロシンキナーゼ阻害剤との組合せ製品及びそれらの使用
EP2968340A4 (fr)	2013-03-15	2016-08-10	Intellikine Llc	Combinaison d'inhibiteurs de kinase et ses utilisations
WO2015084804A1 (fr)	2013-12-03	2015-06-11	Novartis Ag	Combinaison d'un inhibiteur de mdm2 et d'un inhibiteur de braf, et leur utilisation
WO2016011658A1 (fr)	2014-07-25	2016-01-28	Novartis Ag	Polythérapie
ES2831416T3 (es)	2014-07-31	2021-06-08	Novartis Ag	Terapia de combinación de un inhibidor de MET y un inhibidor de EGFR
CN113194752A (zh)	2018-06-01	2021-07-30	康奈尔大学	Pi3k相关疾病或病症的组合疗法
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en) *	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
WO1988003147A1 (fr) *	1986-10-31	1988-05-05	Warner-Lambert Company	Adenosines a substitution n6 selectionees ayant une activite de liaison a2 selective
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5877180A (en) *	1994-07-11	1999-03-02	University Of Virginia Patent Foundation	Method for treating inflammatory diseases with A2a adenosine receptor agonists
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
AU5879299A (en) *	1998-10-16	2000-05-08	Monaghan, Sandra Marina	Adenine derivatives

1999
- 1999-10-14 GB GBGB9924363.6A patent/GB9924363D0/en not_active Ceased
2000
- 2000-09-14 HN HN2000000204A patent/HN2000000204A/es unknown
- 2000-09-26 PA PA20008503501A patent/PA8503501A1/es unknown
- 2000-10-06 BR BR0011776-5A patent/BR0011776A/pt not_active IP Right Cessation
- 2000-10-06 NZ NZ515323A patent/NZ515323A/en unknown
- 2000-10-06 HU HU0203483A patent/HUP0203483A2/hu unknown
- 2000-10-06 KR KR1020027004748A patent/KR20020037774A/ko not_active Abandoned
- 2000-10-06 WO PCT/IB2000/001444 patent/WO2001027130A1/fr not_active Ceased
- 2000-10-06 EE EEP200200193A patent/EE200200193A/xx unknown
- 2000-10-06 CN CNB008096287A patent/CN1151167C/zh not_active Expired - Fee Related
- 2000-10-06 YU YU88901A patent/YU88901A/sh unknown
- 2000-10-06 EP EP00964566A patent/EP1220863B1/fr not_active Expired - Lifetime
- 2000-10-06 IL IL14634200A patent/IL146342A0/xx unknown
- 2000-10-06 EA EA200101107A patent/EA004655B1/ru not_active IP Right Cessation
- 2000-10-06 DE DE60002356T patent/DE60002356T2/de not_active Expired - Fee Related
- 2000-10-06 DK DK00964566T patent/DK1220863T3/da active
- 2000-10-06 AU AU75488/00A patent/AU768308B2/en not_active Ceased
- 2000-10-06 TR TR2002/00985T patent/TR200200985T2/xx unknown
- 2000-10-06 CZ CZ20021223A patent/CZ20021223A3/cs unknown
- 2000-10-06 CA CA002387531A patent/CA2387531C/fr not_active Expired - Fee Related
- 2000-10-06 AP APAP/P/2002/002478A patent/AP1442A/en active
- 2000-10-06 JP JP2001530348A patent/JP3994007B2/ja not_active Expired - Fee Related
- 2000-10-06 OA OA1200200102A patent/OA12059A/en unknown
- 2000-10-06 UA UA2002042943A patent/UA66945C2/uk unknown
- 2000-10-06 DZ DZ003159A patent/DZ3159A1/fr active
- 2000-10-06 MX MXPA02003812A patent/MXPA02003812A/es active IP Right Grant
- 2000-10-06 SK SK484-2002A patent/SK4842002A3/sk unknown
- 2000-10-06 SI SI200030102T patent/SI1220863T1/xx unknown
- 2000-10-06 PL PL00354932A patent/PL354932A1/xx not_active Application Discontinuation
- 2000-10-06 GE GEAP20006243A patent/GEP20043269B/en unknown
- 2000-10-06 AT AT00964566T patent/ATE238336T1/de not_active IP Right Cessation
- 2000-10-06 HK HK02108605.8A patent/HK1047110B/zh not_active IP Right Cessation
- 2000-10-06 ES ES00964566T patent/ES2193990T3/es not_active Expired - Lifetime
- 2000-10-06 PT PT00964566T patent/PT1220863E/pt unknown
- 2000-10-12 MY MYPI20004790A patent/MY136242A/en unknown
- 2000-10-12 CO CO00077985A patent/CO5251399A1/es not_active Application Discontinuation
- 2000-10-12 GT GT200000172A patent/GT200000172A/es unknown
- 2000-10-12 EC EC2000003712A patent/ECSP003712A/es unknown
- 2000-10-13 AR ARP000105421A patent/AR023275A1/es unknown
- 2000-10-13 UY UY26397A patent/UY26397A1/es not_active Application Discontinuation
- 2000-10-13 TN TNTNSN00202A patent/TNSN00202A1/fr unknown
- 2000-10-13 PE PE2000001098A patent/PE20010755A1/es not_active Application Discontinuation
- 2000-10-13 SV SV2000000198A patent/SV2002000198A/es unknown
- 2000-10-16 US US09/688,624 patent/US6350735B1/en not_active Expired - Fee Related
2001
- 2001-11-16 IS IS6165A patent/IS6165A/is unknown
2002
- 2002-02-08 CR CR6584A patent/CR6584A/es not_active Application Discontinuation
- 2002-04-02 BG BG106569A patent/BG106569A/xx unknown
- 2002-04-09 MA MA26590A patent/MA26828A1/fr unknown
- 2002-04-10 NO NO20021692A patent/NO20021692D0/no not_active Application Discontinuation
- 2002-04-11 ZA ZA200202849A patent/ZA200202849B/xx unknown

Also Published As

Publication number	Publication date
GEP20043269B (en)	2004-06-25
US6350735B1 (en)	2002-02-26
MXPA02003812A (es)	2002-09-30
AR023275A1 (es)	2002-09-04
SI1220863T1 (en)	2003-10-31
UY26397A1 (es)	2001-05-31
CN1358192A (zh)	2002-07-10
GT200000172A (es)	2002-04-05
CR6584A (es)	2004-01-14
BG106569A (en)	2002-12-29
CO5251399A1 (es)	2003-02-28
CA2387531A1 (fr)	2001-04-19
UA66945C2 (uk)	2004-06-15
CN1151167C (zh)	2004-05-26
OA12059A (en)	2006-05-03
JP2003511459A (ja)	2003-03-25
DK1220863T3 (da)	2003-08-11
GB9924363D0 (en)	1999-12-15
AU7548800A (en)	2001-04-23
YU88901A (sh)	2004-09-03
PA8503501A1 (es)	2002-02-21
EE200200193A (et)	2003-06-16
MA26828A1 (fr)	2004-12-20
AP2002002478A0 (en)	2002-06-30
DE60002356D1 (de)	2003-05-28
ATE238336T1 (de)	2003-05-15
TR200200985T2 (tr)	2002-10-21
NZ515323A (en)	2003-10-31
KR20020037774A (ko)	2002-05-22
HN2000000204A (es)	2001-06-21
BR0011776A (pt)	2002-03-12
HK1047110B (zh)	2005-03-04
PL354932A1 (en)	2004-03-22
CA2387531C (fr)	2006-12-05
HK1047110A1 (en)	2003-02-07
NO20021692L (no)	2002-04-10
ES2193990T3 (es)	2003-11-16
IS6165A (is)	2001-11-16
EP1220863B1 (fr)	2003-04-23
EP1220863A1 (fr)	2002-07-10
HUP0203483A2 (hu)	2003-02-28
WO2001027130A1 (fr)	2001-04-19
AP1442A (en)	2005-06-29
AU768308B2 (en)	2003-12-04
SK4842002A3 (en)	2003-06-03
EA004655B1 (ru)	2004-06-24
NO20021692D0 (no)	2002-04-10
TNSN00202A1 (fr)	2005-11-10
MY136242A (en)	2008-08-29
DE60002356T2 (de)	2004-02-19
PT1220863E (pt)	2003-07-31
ZA200202849B (en)	2003-06-25
SV2002000198A (es)	2002-02-05
CZ20021223A3 (cs)	2003-05-14
DZ3159A1 (fr)	2001-04-19
PE20010755A1 (es)	2001-07-17
JP3994007B2 (ja)	2007-10-17
ECSP003712A (es)	2002-05-23
EA200101107A1 (ru)	2002-10-31

Publication	Publication Date	Title
IL148331A0 (en)	2002-09-12	Purine derivatives
IL146342A0 (en)	2002-07-25	Purine derivatives
IL147098A0 (en)	2002-08-14	Purine derivatives
GC0000287A (en)	2006-11-01	Purine derivatives
EG23817A (en)	2007-09-19	4-Phenyl-pyridine derivatives
GB0003960D0 (en)	2000-04-12	Purine derivatives
GB0022695D0 (en)	2000-11-01	Purine Derivatives
IL152529A0 (en)	2003-05-29	Purine derivatives
GC0000183A (en)	2006-03-29	3-Phenyl-pyridine derivatives
GC0000338A (en)	2007-03-31	5-Phenyl-pyrimidine derivatives
IL145739A0 (en)	2002-07-25	13-methyl-erythromycin derivatives
GC0000191A (en)	2006-03-29	4-Phenyl-pyrimidine derivatives
GC0000256A (en)	2006-11-01	Ethanesulfonyl-piperidine derivatives
GB9925880D0 (en)	1999-12-29	B-Carboline derivatives
IL145949A0 (en)	2002-07-25	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
GB0014048D0 (en)	2000-08-02	Purine derivatives
GB0024920D0 (en)	2000-11-22	Purine derivatives
PL344600A1 (en)	2001-11-05	Adenosine a3
GB9907134D0 (en)	1999-05-19	Antimor napthylcombretastatin derivatives
IL146282A0 (en)	2002-07-25	Thio-oxindole derivatives